US Stock MarketDetailed Quotes
PTIXW PROTAGENIC THERAPEUTICS INC C/WTS 13/04/2025 (TO PUR COM)
- 0.0180
- -0.0080-30.77%
Close May 15 16:00 ET
0Market Cap0.00P/E (TTM)
0.0180High0.0180Low300Volume0.0180Open0.0260Pre Close5.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.039852wk High0.00P/B0Float Cap0.002452wk Low--Dividend TTM0Shs Float0.7999Historical High--Div YieldTTM0.00%Amplitude0.0024Historical Low0.0160Avg Price1Lot Size
PROTAGENIC THERAPEUTICS INC C/WTS 13/04/2025 (TO PUR COM) News
10-K/A: Annual report (Amendment)
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice
Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, tod
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg